These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7523539)

  • 21. New advances in our understanding of the "unique" RNase L in host pathogen interaction and immune signaling.
    Gusho E; Baskar D; Banerjee S
    Cytokine; 2020 Sep; 133():153847. PubMed ID: 27595182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNase L plays a role in the antiviral response to West Nile virus.
    Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
    J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
    Malathi K; Dong B; Gale M; Silverman RH
    Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
    Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
    J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bipartite model of 2-5A-dependent RNase L.
    Dong B; Silverman RH
    J Biol Chem; 1997 Aug; 272(35):22236-42. PubMed ID: 9268370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity.
    Huang H; Zeqiraj E; Dong B; Jha BK; Duffy NM; Orlicky S; Thevakumaran N; Talukdar M; Pillon MC; Ceccarelli DF; Wan LC; Juang YC; Mao DY; Gaughan C; Brinton MA; Perelygin AA; Kourinov I; Guarné A; Silverman RH; Sicheri F
    Mol Cell; 2014 Jan; 53(2):221-34. PubMed ID: 24462203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RNase L, a crucial mediator of innate immunity and other cell functions].
    Bisbal C; Salehzada T
    Med Sci (Paris); 2008 Oct; 24(10):859-64. PubMed ID: 18950583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interferon-inducible recombinant human RNase L causes RNA degradation and inhibition of cell growth in Escherichia coli.
    Pandey M; Rath PC
    Biochem Biophys Res Commun; 2004 Apr; 317(2):586-97. PubMed ID: 15063798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase L.
    Xi J; Snieckute G; Martínez JF; Arendrup FSW; Asthana A; Gaughan C; Lund AH; Bekker-Jensen S; Silverman RH
    Cell Rep; 2024 Apr; 43(4):113998. PubMed ID: 38551960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
    Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
    Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.
    Rivas C; Gil J; Mĕlková Z; Esteban M; Díaz-Guerra M
    Virology; 1998 Apr; 243(2):406-14. PubMed ID: 9568039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells.
    Díaz-Guerra M; Rivas C; Esteban M
    Virology; 1997 Sep; 236(2):354-63. PubMed ID: 9325243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of a molecular form of interferon-regulated RNase L in the cytoskeleton.
    Tnani M; Aliau S; Bayard B
    J Interferon Cytokine Res; 1998 Jun; 18(6):361-8. PubMed ID: 9660242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of the interferon-inducible RNA-degrading enzyme, RNase L, by stress-inducing agents in the human cervical carcinoma cells.
    Pandey M; Bajaj GD; Rath PC
    RNA Biol; 2004 May; 1(1):21-7. PubMed ID: 17200614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis and origins of the human and mouse RNase L genes: mediators of interferon action.
    Zhou A; Nie H; Silverman RH
    Mamm Genome; 2000 Nov; 11(11):989-92. PubMed ID: 11063255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of RNABP, an RNA binding protein that associates with RNase L.
    Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
    J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
    Rusch L; Zhou A; Silverman RH
    J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
    Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
    EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNase L: its biological roles and regulation.
    Liang SL; Quirk D; Zhou A
    IUBMB Life; 2006 Sep; 58(9):508-14. PubMed ID: 17002978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.